Newcastle University

The funding is being provided by three charities under a program designed to facilitate collaboration between research groups from different institutions.

By sequencing 72,501 individual kidney cells, researchers saw some shared transcriptional patterns in kidney cancers and developing or adult kidneys.

Diploid hopes to lighten the workload of clinical geneticists drowning in next-generation sequencing data.

UK regulators have given the clinic the green light to offer the service, the Guardian reports.

NEW YORK (GenomeWeb News) – Two forms of a rare subgroup of acute lymphoblastic leukemia form through chromothripsis, or catastrophic chromosome shattering, researchers from the Wellcome Trust S

NEW YORK (GenomeWeb News) – Four European research teams will use €38 million ($50.8 million) in funding from the European Union to harness genomic knowledge in developing new diagnostics and treatments for a range of rare diseases, Newcastle University said today.

NEW YORK (GenomeWeb News) – DNA2.0 today announced a deal with Newcastle University to develop a protein expression system for Bacillus subtillis.

NEW YORK (GenomeWeb News) – The UK's Engineering and Physical Sciences Research Council today announced a £5 million ($7.9 million) five-year grant to a consortium of universities to develop a Web-based synthetic biology platform.

In its companion diagnostics development program for an investigational PARP inhibitor oncologic, Pfizer is pursuing methylation-specific biomarkers rather than BRCA gene mutations to help personalize the drug.

Nine members of the HMO Research Network "will use detailed clinical profiles to search for potential subjects to enroll into … serious adverse events research projects using their electronic medical record databases," iSAEC said in a statement.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.